Biotechblog – Page 1037 – Biotechnology business, policy, and more!

VC’s don’t read business plans; So, what to do?

A recent UMD study has found that VCs pay little attention ot the content of business plans.This is not much […]

I’ve got two appearances at BIO related to the Scientific American worldView project: On May 18th I’ll be participating in

For all the talk of the numerous biotechnology companies with mere months of cash left and the predictions of looming

In 2005 India mostly strengthened their patent laws to meet international norms, with the distinct requirement that new drug products

In 2005 India mostly strengthened their patent laws to meet international norms, with the distinct requirement that new drug products

John Avellanet, a frequent contributor to this blog, is giving a talk for my biotechnology management class at the NIH

The Scientific American WorldView project, where I’ve been serving as lead editorial consultant, is ramping up for its May 20th

Does Roche’s recent acquisition of Genentech mean the end of the big-biotech business model? Has Genentech lost it’s independence? Not

I’ll be giving a talk at the Johns Hopkins Carey Business School Entrepreneurship Conference on March 21st titled “Entrepreneurship: What

The April 2009 issue of the Journal of Commercial Biotechnology is now available. This special issue on education was guest-edited